Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

16. Oktober 2019 08:19 ET | Quelle: Biomerica, Inc.

Biomerica Reports 1st Quarter Fiscal 2020 Financials

IRVINE, Calif., Oct. 16, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $1,194,415 for the three months ending August 31, 2019, compared to $1,272,870 for the...
30. August 2019 08:30 ET | Quelle: Biomerica, Inc.

Biomerica Announces Fiscal Year End 2019 Financial Results

IRVINE, Calif., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported net sales for the fiscal year 2019 were $5,200,682...
21. August 2019 08:19 ET | Quelle: Biomerica, Inc.

Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia

IRVINE, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced the Republic of Colombia Ministry of Health and Social Protection Institute National Surveillance of Drugs...
05. Juni 2019 08:19 ET | Quelle: Biomerica, Inc.

Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million.

IRVINE, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced it has signed an exclusive sales and distribution agreement with MaxHealth for the sale of its EZ Detect...
16. April 2019 09:18 ET | Quelle: Biomerica, Inc.

Biomerica Announces Third Quarter Financial Results

IRVINE, Calif., April 16, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $4,034,822 for the nine months ending February 28, 2019, compared to $4,433,785 for the...
08. April 2019 08:19 ET | Quelle: Biomerica, Inc.

Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS)

IRVINE, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for...
05. Februar 2019 08:19 ET | Quelle: Biomerica, Inc.

Biomerica Announces Updates for H. Pylori Clinical Studies

IRVINE, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today regulatory and clinical advancements in its development program for its H. pylori diagnostic product. ...
15. Januar 2019 08:19 ET | Quelle: Biomerica, Inc.

Biomerica Announces Second Quarter Financial Results

IRVINE, Calif., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) today reported net sales of $1,500,791 for the three months ended November 30, 2018, compared to $1,613,636 for the...
28. November 2018 08:19 ET | Quelle: Biomerica, Inc.

Medline and Biomerica sign agreement for distribution of Biomerica’s colorectal screening test to help identify an early warning sign of colorectal cancer

IRVINE, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced that is has signed a three year agreement with Medline Industries for the distribution of Biomerica’s EZ...
07. November 2018 09:42 ET | Quelle: Biomerica, Inc.

Biomerica’s Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis (UC) in Prospective Clinical Stud

Eliminating positive foods identified by Biomerica’s diagnostic product showed statistically significant improvements (p<0.05) in both Quality of Life (FDA Instrument) and disease activity (Mayo...

Vorherige Seite